Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Return on Tangible Equity 2011-2025 | ZTS

Current and historical return on tangible equity values for Zoetis (ZTS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Zoetis Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $2.52B $0.86B 247.17%
2024-12-31 $2.49B $0.92B 235.86%
2024-09-30 $2.43B $1.30B 231.93%
2024-06-30 $2.34B $1.00B 246.67%
2024-03-31 $2.39B $1.00B 276.34%
2023-12-31 $2.34B $0.89B 323.09%
2023-09-30 $2.28B $0.91B 399.12%
2023-06-30 $2.21B $0.66B 437.78%
2023-03-31 $2.07B $0.44B 450.95%
2022-12-31 $2.11B $0.28B 435.65%
2022-09-30 $2.07B $0.65B 402.92%
2022-06-30 $2.09B $0.47B 462.65%
2022-03-31 $2.07B $0.54B 622.99%
2021-12-31 $2.04B $0.39B 1623.11%
2021-09-30 $1.98B $0.41B -1533.46%
2021-06-30 $1.91B $-0.01B -424.22%
2021-03-31 $1.77B $-0.29B -220.44%
2020-12-31 $1.64B $-0.63B -142.93%
2020-09-30 $1.66B $-0.88B -116.15%
2020-06-30 $1.62B $-1.43B -97.16%
2020-03-31 $1.61B $-1.65B -88.98%
2019-12-31 $1.50B $-1.77B -77.07%
2019-09-30 $1.46B $-1.81B -69.65%
2019-06-30 $1.38B $-2.01B -60.29%
2019-03-31 $1.39B $-2.19B -70.55%
2018-12-31 $1.43B $-2.38B -87.70%
2018-09-30 $1.16B $-2.54B -90.83%
2018-06-30 $1.12B $-0.76B -130.56%
2018-03-31 $0.98B $-0.84B -108.13%
2017-12-31 $0.86B $-0.99B -89.19%
2017-09-30 $0.94B $-0.83B -91.59%
2017-06-30 $0.88B $-0.96B -79.03%
2017-03-31 $0.86B $-1.09B -71.16%
2016-12-31 $0.82B $-1.21B -63.23%
2016-09-30 $0.69B $-1.18B -49.77%
2016-06-30 $0.64B $-1.32B -51.69%
2016-03-31 $0.38B $-1.48B -35.28%
2015-12-31 $0.34B $-1.55B -39.85%
2015-09-30 $0.44B $-0.59B -80.00%
2015-06-30 $0.42B $-0.66B -84.98%
2015-03-31 $0.59B $-0.60B -132.51%
2014-12-31 $0.58B $-0.37B -125.31%
2014-09-30 $0.56B $-0.35B -96.98%
2014-06-30 $0.53B $-0.48B -72.76%
2014-03-31 $0.52B $-0.67B -60.79%
2013-12-31 $0.50B $-0.82B -52.21%
2013-09-30 $0.39B $-0.93B -183.06%
2013-06-30 $0.42B $-0.99B 2126.58%
2013-03-31 $0.47B $-1.12B 173.51%
2012-12-31 $0.44B $2.19B 79.71%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $66.376B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.750B 26.44
Takeda Pharmaceutical (TAK) Japan $46.552B 9.50
Daiichi Sankyo, - (DSNKY) Japan $46.222B 23.69
BeOne Medicines - (ONC) Switzerland $31.576B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.096B 0.00
Summit Therapeutics (SMMT) United States $19.080B 0.00
Merck (MKKGY) Germany $16.874B 10.97
Shionogi (SGIOY) Japan $15.432B 15.46
United Therapeutics (UTHR) United States $13.595B 11.76
Neurocrine Biosciences (NBIX) United States $12.784B 38.13
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.440B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.971B 0.00
Corcept Therapeutics (CORT) United States $7.754B 65.12
Grifols, S.A (GRFS) Spain $7.288B 0.00
Stevanato Group S.p.A (STVN) Italy $6.611B 38.98
Ionis Pharmaceuticals (IONS) United States $6.600B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.430B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.827B 13.46
NewAmsterdam Pharma (NAMS) Netherlands $2.807B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.682B 0.00
Hypermarcas (HYPMY) Brazil $2.579B 19.39
Catalyst Pharmaceuticals (CPRX) United States $2.489B 8.34
Centessa Pharmaceuticals (CNTA) United Kingdom $2.286B 0.00
Ocular Therapeutix (OCUL) United States $2.171B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.753B 0.00
Dyne Therapeutics (DYN) United States $1.653B 0.00
ARS Pharmaceuticals (SPRY) United States $1.636B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.490B 22.20
Guardian Pharmacy Services (GRDN) United States $1.432B 0.00
Evotec AG (EVO) Germany $1.353B 0.00
Ardelyx (ARDX) United States $1.350B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.296B 0.00
Harrow (HROW) United States $1.289B 0.00
Collegium Pharmaceutical (COLL) United States $1.193B 6.52
Xeris Biopharma Holdings (XERS) United States $1.179B 0.00
Cronos Group (CRON) Canada $0.983B 0.00
Enliven Therapeutics (ELVN) United States $0.927B 0.00
Akebia Therapeutics (AKBA) United States $0.880B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.731B 0.00
Siga Technologies (SIGA) United States $0.666B 8.23
ProKidney (PROK) United States $0.656B 0.00
Zevra Therapeutics (ZVRA) United States $0.643B 0.00
Organogenesis (ORGO) United States $0.620B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.619B 6.38
KalVista Pharmaceuticals (KALV) United States $0.612B 0.00
Elite Pharmaceuticals (ELTP) United States $0.608B 0.00
Bioventus (BVS) United States $0.600B 14.62
Theravance Biopharma (TBPH) United States $0.596B 49.67
Relay Therapeutics (RLAY) United States $0.578B 0.00
Xencor (XNCR) United States $0.553B 0.00
Tourmaline Bio (TRML) United States $0.552B 0.00
USANA Health Sciences (USNA) United States $0.549B 11.26
Tonix Pharmaceuticals Holding (TNXP) United States $0.524B 0.00
Oruka Therapeutics (ORKA) United States $0.522B 0.00
Savara (SVRA) United States $0.446B 0.00
Aquestive Therapeutics (AQST) United States $0.377B 0.00
Esperion Therapeutics (ESPR) United States $0.355B 0.00
Nanobiotix S.A (NBTX) France $0.355B 0.00
Aldeyra Therapeutics (ALDX) United States $0.321B 0.00
Larimar Therapeutics (LRMR) United States $0.306B 0.00
Altimmune (ALT) United States $0.294B 0.00
Nektar Therapeutics (NKTR) United States $0.293B 0.00
4D Molecular Therapeutics (FDMT) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.287B 18.71
AleAnna (ANNA) United States $0.287B 0.00
OmniAb (OABI) United States $0.239B 0.00
Galectin Therapeutics (GALT) United States $0.239B 0.00
MediWound (MDWD) Israel $0.203B 0.00
Heron Therapeutics (HRTX) United States $0.201B 0.00
Journey Medical (DERM) United States $0.199B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Aclaris Therapeutics (ACRS) United States $0.178B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Lyell Immunopharma (LYEL) United States $0.163B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.159B 24.56
MEI Pharma (MEIP) United States $0.155B 0.00
Lexeo Therapeutics (LXEO) United States $0.155B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Avita Medical (RCEL) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.130B 0.00
Avalo Therapeutics (AVTX) United States $0.123B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Liminatus Pharma (LIMN) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.112B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Dominari Holdings (DOMH) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Surrozen (SRZN) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.41
VAXART, INC (VXRT) United States $0.087B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
Achieve Life Sciences (ACHV) Canada $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
BioNxt Solutions (BNXTF) Canada $0.079B 0.00
Nutriband (NTRB) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Pyxis Oncology (PYXS) United States $0.064B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
DURECT (DRRX) United States $0.059B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Unicycive Therapeutics (UNCY) United States $0.054B 0.00
Wellgistics Health (WGRX) United States $0.054B 0.00
Fractyl Health (GUTS) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Plus Therapeutics (PSTV) United States $0.044B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.044B 26.45
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
FibroGen (FGEN) United States $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
Enlivex Therapeutics (ENLV) Israel $0.037B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Mural Oncology (MURA) Ireland $0.029B 0.00
Vivos Therapeutics (VVOS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
BioVie (BIVI) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.83
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00